Temporary mechanical circulatory support with the iVAC 2L transaortic device in high-risk percutaneous coronary intervention — a multicenter experience
Authors:
- E. A. AvetisyanEAE. A. Avetisyan
- O. B. DorogunODO. B. Dorogun
- E. V. KrasnoperovaEKE. V. Krasnoperova
- R. S. TarasovR. S. Tarasov
- V. I. GanyukovVGV. I. Ganyukov
- A. E. BaevABA. E. Baev
- L. G. ShestakovaLSL. G. Shestakova
- O. L. PolonetskyOPO. L. Polonetsky
- V. V. BazylevVBV. V. Bazylev
- M. E. EvdokimovMEM. E. Evdokimov
- M. G. ShmatkovMSM. G. Shmatkov
- D. V. PevznerDPD. V. Pevzner
Open Access
- 23 July 2024
- journal article
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (1) , 5856
Abstract
Aim. To analyze the multicenter international experience of high-risk protected percutaneous coronary intervention (PCI) procedures using the transaortic temporary pulsatile mechanical circulatory support (MCS) device iVAC 2L (PulseCath B. V., Amsterdam, the Netherlands).Material and methods. The pilot prospective-retrospective international multi-center observational study included patients with multivessel and/or complex coronary lesions, indications for coronary revascularization and refusal of the heart team from coronary artery bypass grafting and unprotected PCI due to a high risk of complications. PCI was performed with a temporary MCS using the iVAC 2L device in five clinics in Russia and Belarus.Results. From February 2023 to February 2024, 24 patients were included in the study. The median age was 69,0 years (interquartile range (IQR): 63,5-71,8); 87,5% were men. Twenty patients (83,3%) underwent elective PCI and four patients (16,7%) due to acute coronary syndrome (ACS) as follows: three with non-ST-segment elevation myocardial infarction and one with ST-segment elevation myocardial infarction (STEMI). The patient with STEMI underwent PCI against the background of acute heart failure (AHF). The median MCS time was 66,0 min (IQR: 43,0-98,0). Technical success of PCI was achieved in 100% of patients. The median initial and residual SYNTAX scores were 35,0 (IQR: 25,6-41,4) and 8,0 (IQR: 5,0-17,5), respectively. The median left ventricular ejection fraction before PCI and 7 days after was 44,0% (IQR: 31,0-54,0) and 48,0% (IQR: 36,5-53,5), respectively. In two cases (8,3%), major bleeding from the access site of the MCS device was observed. There were 2 fatal outcomes as follows: during elective PCI due to progression of acute left ventricular failure and in the late period due to septic shock after emergency PCI.Conclusion. PCI with MCP by the iVAC 2L device is an applicable and relatively safe tactic of coronary revascularization in patients with a high risk of complications, including in the conditions of ACS and AHF.Keywords
This publication has 14 references indexed in Scilit:
- Comparison of a pulsatile and a continuous flow left ventricular assist device in high-risk PCIInternational Journal of Cardiology, 2022
- Effect of Next Generation Pulsatile Mechanical Circulatory Support on Cardiac Mechanics: The PULSE TrialCardiovascular Revascularization Medicine, 2022
- Effectiveness and Safety of a Prolonged Hemodynamic Support by the IVAC2L System in Healthy and Cardiogenic Shock PigsFrontiers in Cardiovascular Medicine, 2022
- First implantation of the pulsatile left ventricular assist device iVAC2L in a heart failure patient infected with influenza type AHellenic Journal of Cardiology, 2021
- Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devicesEuropean Heart Journal: Acute Cardiovascular Care, 2021
- Outcome of extracorporeal membrane oxygenation support for high-risk percutaneous coronary intervention in non-ST-segment elevation acute coronary syndromeJournal of Cardiovascular Medicine, 2020
- The Role of Hemodynamic Support in High-risk Percutaneous Coronary InterventionUS Cardiology Review, 2020
- PulseCath iVAC2L: next-generation Pulsatile Mechanical Circulatory SupportFuture Cardiology, 2020
- High-risk PCI under support of a pulsatile left ventricular assist device – First German experience with the iVAC2L systemInternational Journal of Cardiology, 2019
- ‘Ten commandments’ for the 2018 ESC/EACTS Guidelines on Myocardial RevascularizationEuropean Heart Journal, 2019